EGFR and non-small cell lung carcinoma: The cobas EGFR Mutation Test v2 (Roche Molecular Systems, Inc.)is a real-time PCR assay designed to detect specific mutations of the EGFR gene in cfDNA from NSCLC patients (Malapelle et al., 2017; Szpechcinski et al., 2021).